The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors.

Boerman, O C

The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors. [electronic resource] - International journal of cancer May 1992 - 470-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0020-7136

10.1002/ijc.2910510322 doi


Animals
Antibodies, Monoclonal--metabolism
Colonic Neoplasms--metabolism
Female
Humans
Iodine Radioisotopes--metabolism
Mice
Mice, Nude
Radioimmunotherapy